Applied Molecular Transport Inc.

1.9600.00Vol 108.40K1Y Perf -93.73%
Aug 12th, 2022 16:00 DELAYED
BID1.92 ASK1.99
Open1.95 Previous Close1.96
Pre-Market- After-Market1.94
 - -  -0.02 -1.02%
Target Price
17.80 
Analyst Rating
Moderate Buy 1.67
Potential %
808.16 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/100/-11 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
100/100/-35 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
100/100/57 
Income Ranking
 —    -
Price Range Ratio 52W %
0.79 
Earnings Rating
Market Cap76.24M 
Earnings Date
9th Aug 2022
Alpha-0.08 Standard Deviation0.22
Beta1.76 

Today's Price Range

1.880.00

52W Range

1.7133.28

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.51%
1 Month
-24.03%
3 Months
-51.96%
6 Months
-74.28%
1 Year
-93.73%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AMTI1.960.00000.00
AAPL172.123.63002.15
GOOG122.652.83002.36
MSFT291.914.89001.70
XOM94.000.81000.87
WFC45.940.69001.52
JNJ165.30-1.8400-1.10
FB196.640.99000.51
GE79.931.03001.31
JPM122.131.99001.66
 
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.65-0.93-43.08
Q01 2022-0.70-1.10-57.14
Q04 2021-0.63-0.78-23.81
Q03 2021-0.60-0.68-13.33
Q02 2021-0.58-0.62-6.90
Q01 2021-0.57-0.58-1.75
Q04 2020-0.46-0.3817.39
Q03 2020-0.41-0.48-17.07
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.65
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume108.40K
Shares Outstanding38.90K
Shares Float13.01M
Trades Count1.54K
Dollar Volume212.48K
Avg. Volume324.66K
Avg. Weekly Volume241.43K
Avg. Monthly Volume318.77K
Avg. Quarterly Volume413.78K

Applied Molecular Transport Inc. (NASDAQ: AMTI) stock closed at 1.96 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 108.40K shares and market capitalization of 76.24M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 49 people. Applied Molecular Transport Inc. CEO is Tahir Mahmood.

The one-year performance of Applied Molecular Transport Inc. stock is -93.73%, while year-to-date (YTD) performance is -85.98%. AMTI stock has a five-year performance of %. Its 52-week range is between 1.71 and 33.28, which gives AMTI stock a 52-week price range ratio of 0.79%

Applied Molecular Transport Inc. currently has a PE ratio of -0.60, a price-to-book (PB) ratio of 0.78, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -72.52%, a ROC of -76.44% and a ROE of -88.09%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Applied Molecular Transport Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.65 for the next earnings report. Applied Molecular Transport Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Applied Molecular Transport Inc. is Moderate Buy (1.67), with a target price of $17.8, which is +808.16% compared to the current price. The earnings rating for Applied Molecular Transport Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Applied Molecular Transport Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Applied Molecular Transport Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.28, ATR14 : 0.25, CCI20 : -30.15, Chaikin Money Flow : -0.34, MACD : -0.23, Money Flow Index : 29.80, ROC : 1.03, RSI : 32.09, STOCH (14,3) : 58.14, STOCH RSI : 1.00, UO : 46.22, Williams %R : -41.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Applied Molecular Transport Inc. in the last 12-months were: Bittoo Kanwar (Option Excercise at a value of $74 970), David A. Lamond (Buy at a value of $210 850), Helen S. Kim (Sold 9 986 shares of value $300 331 ), Randall Mrsny (Buy at a value of $52 464), Shawn Cross (Option Excercise at a value of $46 100), Shawn Cross (Sold 10 000 shares of value $301 193 ), Tahir Mahmood (Buy at a value of $23 640)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.67
Moderate Buy
1.67
Strong Buy
1.00

Applied Molecular Transport Inc.

Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.

CEO: Tahir Mahmood

Telephone: +1 650 392-0420

Address: 1 Tower Place, South San Francisco 94080, CA, US

Number of employees: 49

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

75%25%

Bearish Bullish

71%29%

Bearish Bullish

76%24%

TipRanks News for AMTI

Mon, 25 Apr 2022 15:35 GMT Applied Molecular Transport (AMTI) Receives a Buy from JMP Securities

- TipRanks. All rights reserved.

Tue, 01 Mar 2022 10:38 GMT Applied Molecular Transport (AMTI) Gets a Buy Rating from Leerink Partners

- TipRanks. All rights reserved.

News

Stocktwits